Mark R. Ziebell
Overview
Mark R. Ziebell received an average of $823K in total compensation, including $361K in salary, at Peregrine Pharmaceuticals from 2013 to 2023.
2023Peregrine PharmaceuticalsGeneral Counsel and Corporate Secretary
2022Peregrine PharmaceuticalsVice President, General Counsel and Corporate Secretary
2021Peregrine PharmaceuticalsVice President, General Counsel and Corporate Secretary
2020Peregrine PharmaceuticalsVice President, General Counsel and Corporate Secretary
2019Peregrine PharmaceuticalsVice President, General Counsel and Corporate Secretary
2018Peregrine PharmaceuticalsVice President, General Counsel and Corporate Secretary
2017Peregrine PharmaceuticalsVice President, General Counsel and Corporate Secretary
2016Peregrine PharmaceuticalsVice President, General Counsel and Corporate Secretary
2014Peregrine PharmaceuticalsVice President, General Counsel and Corporate Secretary
2013Peregrine PharmaceuticalsVice President, General Counsel and Corporate Secretary
Source: SEC filings on August 28, 2023, August 29, 2022, August 27, 2021, August 27, 2020, August 21, 2019, August 17, 2018, and August 28, 2014.
Related executives
We found 13 more executives who work or worked at Peregrine Pharmaceuticals.
Nicholas Green
Peregrine Pharmaceuticals
Chief Executive Officer
Daniel Hart
Peregrine Pharmaceuticals
Chief Financial Officer
Matthew Kwietniak
Peregrine Pharmaceuticals
Chief Commercial Officer
Richard Richieri
Peregrine Pharmaceuticals
Chief Operations Officer
Richard Hancock
Peregrine Pharmaceuticals
Chief Executive Officer
Roger Lias
Peregrine Pharmaceuticals
Chief Executive Officer
Stephen Hedberg
Peregrine Pharmaceuticals
Principal Financial Officer and Principal Accounting Officer
Paul Lytle
Peregrine Pharmaceuticals
Chief Financial Officer
News
Peregrine Pharmaceuticals CEO Nicholas Green's 2023 pay rises 5% to $6.5M
August 28, 2023
Peregrine Pharmaceuticals CEO Nicholas Green's 2022 pay jumps 117% to $6.2M
August 29, 2022
Peregrine Pharmaceuticals CEO Nicholas Green receives $2.8M in 2021
August 27, 2021
Peregrine Pharmaceuticals General Counsel Mark Ziebell's 2020 pay jumps 124% to $1.1M
August 27, 2020
Peregrine Pharmaceuticals CEO Roger Lias' 2019 pay jumps 25% to $880K
August 21, 2019
Peregrine Pharmaceuticals CEO Roger Lias receives $704K in 2018
August 17, 2018